"Chemokines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Class of pro-inflammatory cytokines that have the ability to attract and activate leukocytes. They can be divided into at least three structural branches: C; (CHEMOKINES, C); CC; (CHEMOKINES, CC); and CXC; (CHEMOKINES, CXC); according to variations in a shared cysteine motif.
| Descriptor ID |
D018925
|
| MeSH Number(s) |
D12.644.276.374.200 D12.776.467.374.200 D23.125.300 D23.469.200 D23.529.374.200
|
| Concept/Terms |
Chemokines- Chemokines
- Cytokines, Chemotactic
- Intercrines
- Chemotactic Cytokines
|
Below are MeSH descriptors whose meaning is more general than "Chemokines".
Below are MeSH descriptors whose meaning is more specific than "Chemokines".
This graph shows the total number of publications written about "Chemokines" by people in this website by year, and whether "Chemokines" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 6 | 1 | 7 |
| 1997 | 12 | 3 | 15 |
| 1998 | 9 | 1 | 10 |
| 1999 | 16 | 6 | 22 |
| 2000 | 14 | 10 | 24 |
| 2001 | 6 | 10 | 16 |
| 2002 | 11 | 17 | 28 |
| 2003 | 8 | 23 | 31 |
| 2004 | 18 | 21 | 39 |
| 2005 | 13 | 19 | 32 |
| 2006 | 17 | 27 | 44 |
| 2007 | 12 | 22 | 34 |
| 2008 | 16 | 19 | 35 |
| 2009 | 10 | 14 | 24 |
| 2010 | 13 | 21 | 34 |
| 2011 | 9 | 19 | 28 |
| 2012 | 10 | 20 | 30 |
| 2013 | 8 | 16 | 24 |
| 2014 | 6 | 17 | 23 |
| 2015 | 9 | 20 | 29 |
| 2016 | 10 | 17 | 27 |
| 2017 | 5 | 17 | 22 |
| 2018 | 4 | 19 | 23 |
| 2019 | 6 | 16 | 22 |
| 2020 | 4 | 13 | 17 |
| 2021 | 4 | 22 | 26 |
| 2022 | 2 | 6 | 8 |
| 2023 | 1 | 11 | 12 |
| 2024 | 2 | 8 | 10 |
| 2025 | 1 | 2 | 3 |
Below are the most recent publications written about "Chemokines" by people in Profiles.
-
Distinct clinical outcomes based on multiple serum cytokine and chemokine profiles rather than autoantibody profiles and ultrasound findings in rheumatoid arthritis: a prospective ultrasound cohort study. RMD Open. 2025 Jan 25; 11(1).
-
Distinct myeloid-derived suppressor cell populations in human glioblastoma. Science. 2025 Jan 17; 387(6731):eabm5214.
-
Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients. Nat Commun. 2025 Jan 10; 16(1):586.
-
Association of denosumab with serum cytokines, chemokines, and bone-related factors in patients with rheumatoid arthritis: A post hoc analysis of a multicentre, open-label, randomised, parallel-group study. Mod Rheumatol. 2024 Aug 20; 34(5):936-946.
-
ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity. Cell. 2024 Jun 20; 187(13):3390-3408.e19.
-
Differences in mid-gestational and early postnatal neonatal cytokines and chemokines are associated with patterns of maternal autoantibodies in the context of autism. Cereb Cortex. 2024 May 02; 34(13):50-62.
-
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology. Sci Transl Med. 2024 Apr 17; 16(743):eadj5154.
-
Brief Report: Relationship Between Adiposity and Biomarkers of Aging and Frailty Among Adults Aging With HIV. J Acquir Immune Defic Syndr. 2024 04 01; 95(4):377-382.
-
Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy. Nat Immunol. 2024 Apr; 25(4):644-658.
-
Circulating immune signatures in chronic pancreatitis with and without preceding acute pancreatitis: A pilot study. Pancreatology. 2024 May; 24(3):384-393.